Cardiac Pacemaker Market Analysis | CMI - PowerPoint PPT Presentation

About This Presentation

Cardiac Pacemaker Market Analysis | CMI


Read here the latest updates on the Cardiac Pacemaker Market Analysis published by CMI team – PowerPoint PPT presentation

Number of Views:52


Transcript and Presenter's Notes

Title: Cardiac Pacemaker Market Analysis | CMI

  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//
  • COVID-19 Impact Tracker

  • Cardiac Pacemaker Market, by Product Type
    (Implantable cardiac pacemaker (Single chambered,
    Dual chambered and Biventricular) and External
    cardiac pacemaker), by End User (Hospitals and
    Ambulatory Surgical Centers), and by Region -
    Size, Share, and Forecast to 2026
  • The global cardiac pacemaker market was valued at
    US 5,972.2 million in 2017, and is expected to
    witness a CAGR of 7.3 over the forecast period

Figure 1. Global Cardiac Pacemaker Market value
Analysis (US Mn) and Forecast and Absolute
Cardiac Pacemaker Market Dynamics
  • Increasing incidence of cardiovascular diseases
    worldwide is fueling growth of the Cardiac
    Pacemaker Market. According to the Centre for
    Disease Control and Prevention (CDC) foundation,
    2015, around 800,000 Americans die due to stroke
    and other cardiovascular diseases.
  • Moreover, increasing number of geriatric
    population across the various regions worldwide
    along with high prevalence of heart disease is
    expected to propel demand for implantable cardiac
    pacemakers in the near future. According to the
    data published in the Journal of the Formosan
    Medical Association, in November 2016, around
    half of the world population living in Asia is
    geriatric population and it is growing at faster
    rate, which is increasing burden of Atrial
    Fibrillation (AF) in Asia. According to the same
    source, in 2050, around 72 million people are
    projected to suffer from AF in Asia, which is
    expected to be more than double the combined
    numbers of patients from Europe and the U.S.

  • Introduction of advance technology such as
    wireless and automated pacemaker monitoring
    pacemakers are gaining significant traction among
    healthcare providers. Moreover, increasing
    adoption of advanced technologies in cardiac
    pacemakers such as MRI safe-pacemakers,
    pacemakers with improved battery life, delay the
    progression of persistent Atrial Fibrillation
    (AF) in patients suffering from bradycardia and
    wireless automated technologies have gained
    significant traction among cardiac pacemakers
    market players, which is expected to drive growth
    of cardiac pacemakers market.
  • For instance, in February 2017, Abbott received
    the Food and Drug Administration (FDA) approval
    for its MR-conditional labeling for both of its
    products i.e. Assurity MRI pacemaker and the
    Tendril MRI pacing lead. However, installation of
    pacemakers is associated with risk of developing
    infections in cardiac patients, which may
    restrain market growth. Pacemaker surgery can led
    to various complications such as swelling,
    bruising, bleeding, or infection at the of area
    of pacemaker implantation leading to blood vessel
    or nerve damage, which may reduce the adoption of
    cardiac implants in patients, in turn negatively
    impacting market growth.

Cardiac Pacemaker Market Regional Outlook
  • On the basis of geography, the global cardiac
    pacemaker market is segmented into North America,
    Europe, Asia Pacific, Latin America, Middle East,
    and Africa. North America is expected to hold
    dominant position in this market, owing to
    increasing prevalence of heart diseases and
    adoption of technologically advanced products.
    Moreover, factors such as improved healthcare
    facilities and better reimbursement scenario are
    also driving growth of the cardiac pacemakers
    market in this region.
  • In March 2017, Medtronic issued Medicare
    reimbursement for the first leadless cardiac
    pacemaker Mica Trans catheter Pacing System
    (TPS), which is available in the U.S. Asia
    Pacific is projected to witness significant
    growth in market over the forecast period, owing
    to presence of large patient population,
    increasing healthcare expenditures in emerging
    economies such as India and China which, and
    growing healthcare sector. Emerging economies
    such as Asia Pacific and Latin America has huge
    potential for market growth and is likely to be
    the fastest growing region throughout the
    forecast period.

Key Players
  • Major companies operating in the cardiac
    pacemaker market include Medtronic Plc.,
    BIOTRONIK, Inc., Boston Scientific Corporation,
    Abbott Laboratories, Vitatron Holding B.V., Shree
    Pacetronix Ltd., MEDICO S.p.A., Lepu Medical
    Technology Co Ltd., LivaNova PLC, and Qinming
    Medical, and Cordis Inc.

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Reference https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
  • Phone 1-206-701-6702
  • Email

  • Thank You!
  • Kindly follow CMI Social Media Profiles
    for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//
Write a Comment
User Comments (0)